An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military
Completed · Not applicable
Conditions studied: Posttraumatic Stress Disorder, Combat Disorders
In brief
It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program. The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.
Key facts
- Study ID
- NCT03337750
- Run by
- University of Pennsylvania
- People needed
- 34
- Starts
- 2018-02-12
- Expected to finish
- 2020-02-14
- Last updated by the study team
- 2020-02-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Active-duty military personnel and veterans who have deployed post 9/11
- Seeking treatment for PTSD
- Significant PTSD symptoms as determined by a PCL-5 score greater than or equal to 31
- Has experienced a Criterion A event that is a specific combat-related event or high magnitude operational experience that occurred during a period of recent military deployment
- Able to speak and read English and access to an internet-connected computer
- Indication that the participant plans to be able to participant in the study for the next three months following the first assessment
You may not qualify if…
- Diagnosis of bipolar disorder or psychotic disorder, as determined by participant self-report)
- Current substance dependence, as determined by participant self-report)
- Diagnosis of a moderate or severe traumatic brain injury, as determined by participant self-report)
- Current suicidal ideation severe enough to warrant immediate attention, as determined by participant self-report)
- Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure Therapy or Cognitive Processing Therapy), as determined by participant self-report.
Where it is running
- Center for the Treatment and Study of Anxiety, University of Pennsylvania — Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.